Egyptian President Abdel Fattah al-Sisi said that his country had continued discussions and consultations about the Grand ...

A study tested the effectiveness of mexiletine and lamotrigine in treating non-dystrophic myotonia. Results indicated that ...

President Abdel-Fattah El-Sisi said on Sunday that Egypt’s support for Somalia is not related to Ethiopia but rather to help ...

South Korean drug maker Daewoong Pharmaceutical said Monday that more than 88 percent of its patents registered over the past ...

TheraVet (ISIN: BE0974387194 - ticker: ALVET) today announces a strategic transformation project with H4Orphan aimed at ...

Drifting to sleep very quickly isn't always a good thing, and taking too long can spell trouble, too. Here's the sweet spot, ...

Women’s signals differ compared to men in matters of the heart, say doctors, which is why they still miss out on vital ...

Michelle Monaghan, 42, from North Belfast, had two thirds of her stomach removed after being diagnosed with cancer following ...

US FDA approves Bristol-Myers Squibb’s antipsychotic drug, Cobenfy for treatment of schizophrenia: Maryland Saturday, September 28, 2024, 09:00 Hrs [IST] The US Food and Drug Ad ...

The study, published in Lancet Neurology , detailed the "head-to-head" trial implemented by the researchers to test two drugs ...

On Thursday, the U.S. Food and Drug Administration approved COBENFY, an oral medication that marks the first new class of ...

U.S. FDA Approves Bristol Myers Squibb’s COBENFY, a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults ...